Painful necrotic skin lesions in patients with end-stage renal disease.
Painful necrotic skin lesions in patients with end-stage renal disease.
Common signs and symptoms can vary by wound type and severity.
A clinician evaluates the wound together with the factors that may delay healing.
Calciphylaxis is a medical emergency. Any dialysis patient with new disproportionately painful skin lesions, livedo, or non-healing ulcers should be evaluated immediately. Delay in diagnosis is associated with sepsis and high mortality.
Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds, including calciphylaxis. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities.
Our clinicians work in close coordination with the patient's nephrologist and dialysis center. Wound bed care emphasizes gentle debridement of necrotic eschar (when vascular status permits), aggressive infection control, optimized analgesia, and dressings that manage exudate without causing trauma. We document lesion progression with serial photography to support sodium thiosulfate dosing decisions made by the renal team and to inform any hyperbaric oxygen referrals.
With early recognition, coordinated nephrology management, and disciplined wound care, lesion progression can be halted and selected ulcers can heal. Outcomes are best when calciphylaxis is identified before deep necrosis and sepsis develop.
Calcium deposition narrows the small arterioles in the dermis and subcutaneous fat, causing ischemic injury to nerve endings. Pain is often present before the skin even ulcerates and frequently requires multimodal analgesia.
Yes, smaller and earlier-stage lesions can heal with sodium thiosulfate, optimized dialysis chemistry, and meticulous wound care. Larger truncal ulcers carry a worse prognosis and require aggressive infection control.
Selective debridement of frankly necrotic tissue is helpful when there is adequate perfusion, but aggressive sharp debridement of stable eschar over poorly perfused tissue can worsen outcomes. Decisions are made case by case in coordination with the nephrology team.
Yes. We routinely communicate with dialysis nurses and the attending nephrologist so wound care, sodium thiosulfate infusions, and dressing changes are scheduled around the patient's hemodialysis sessions.
Yes, medically necessary mobile wound care visits for calciphylaxis are typically covered under Medicare Part B when documented appropriately.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.